The Morbidity Management and Disability Prevention (MMDP) Project is a five-year, $35 million global project funded by the U.S. Agency for International Development (USAID). The project helps countries provide high-quality treatment and care for people suffering from the debilitating effects of trachoma and lymphatic filariasis, complementing other major initiatives supporting disease elimination through mass drug administration. With activities in Ethiopia, Cameroon and Burkina Faso and in the global community, the MMDP Project is a key player in the global push to eliminate trachoma and lymphatic filariasis as public health problems by 2020.
The MMDP Project is led by Helen Keller International in partnership with the African Filariasis Morbidity Project, the Kilimanjaro Center for Community Ophthalmology, and RTI International. The project spans from July 22, 2014, through July 21, 2019.